R. Erik Holmlin insider trades

Open-market stock purchases and sales by R. Erik Holmlin, PRESIDENT AND CEO at Bionano Genomics, Inc, from SEC Form 4 filings since Jun 20, 2013.

Track record: 20% of 5 scored buys are up 5% or more since purchase, averaging -42%.

Recent trades

DateStockTradeValue
Feb 17, 2026BNGO Bionano Genomics, IncSold (not open market)$56
Feb 2, 2026BNGO Bionano Genomics, IncBought (not open market)—

Companies traded

  • BNGO Bionano Genomics, Inc: 5 buys, last Feb 17, 2026
  • NSPH Nanosphere Inc: other filings, last Jun 30, 2016

Get free alerts when R. Erik Holmlin files a new trade →